Clinical journal of gastroenterology
Efficacy of budesonide and vedolizumab for IBD-U associated with Muckle-Wells syndrome.
Yuzo Kawata, Kentaro Tominaga, Daisuke Kobayashi, Annenkov Alexey, Kosuke Kojima, Osamu Shibata, Yuichi Kojima, Kazuya Takahashi, Hiroteru Kamimura, Shuji Terai
Published: 202510.1007/s12328-025-02234-8
Abstract
Cryopyrin-associated periodic syndrome (CAPS) is a rare, autosomal dominant inflammatory disorder linked to interleukin (IL)-1β dysregulation. Muckle-Wells syndrome (MWS) is a clinical subtype of CAPS that is often managed with canakinumab, an anti-I…
Preview only. Read the full abstract at the source